{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:05:56Z","timestamp":1791353156829,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.clindermatol.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T19:23:41Z","timestamp":1323372221000},"page":"78-83","source":"Crossref","is-referenced-by-count":71,"title":["Immunosuppressive therapy for autoimmune bullous diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Michael","family":"Meurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.03.013_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0010","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0020","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/14656566.9.9.1519","article-title":"Treatment strategies for pemphigus vulgaris in Japan","volume":"9","author":"Hashimoto","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial","volume":"142","author":"Mentink","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","article-title":"Guidelines for prescribing azathioprine in dermatology","volume":"151","author":"Anstey","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clindermatol.2009.06.018","article-title":"Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety","volume":"28","author":"Schiavo","year":"2010","journal-title":"Facts and controversies. Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000320413","article-title":"State-of-the-art: immunosuppression and biologic therapy","volume":"28","author":"Sandborn","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0060","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.2.6146.1190","article-title":"Azathioprine plus prednisone in treatment of pemphigoid","volume":"2","author":"Burton","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0140-6736(05)63084-X","article-title":"Treatment of pemphigus vulgaris with mycophenolate mofetil","volume":"350","author":"Enk","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in treatment of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","article-title":"An evaluation of the usefulness of mycophenolate mofetil in pemphigus","volume":"149","author":"Powell","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2010.02.052","article-title":"Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission","volume":"64","author":"Strowd","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(97)80092-X","article-title":"Bullous pemphigoid treated with mycophenolate mofetil","volume":"349","author":"B\u00f6hm","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0190-9622(98)70334-2","article-title":"Successful therapy for bullous pemphigoid with mycophenolate mofetil","volume":"39","author":"Nousari","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","article-title":"Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0110","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-4632.2009.04291.x","article-title":"Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus","volume":"49","author":"Bongiorno","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.135.1.57","article-title":"Pulse intravenous cyclophosphamide therapy in pemphigus","volume":"135","author":"Fleischli","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1610-0387.2007.06342.x","article-title":"Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases","volume":"5","author":"Zillikens","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2011.03.013_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07343.x","article-title":"Update on the use of ciclosporin in immune-mediated dermatoses","volume":"155","author":"Griffiths","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0145","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archderm.135.10.1275","article-title":"Methotrexate as an adjuvant treatment for pemphigus vulgaris","volume":"135","author":"Smith","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.013_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1610-0387.2008.06872.x","article-title":"Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid","volume":"7","author":"Hofmann","year":"2009","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T02:56:43Z","timestamp":1543373803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0738081X11000897"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.03.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}